PVH Stock Cash Flow Statements

PVH Corp Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Free Cash Flow

Capital Expenditure

PVH Corp Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-08-03	2025-05-04	2024-11-03	2024-08-04	2024-05-05	2024-02-02	2023-10-29	2023-07-30	2023-04-30	2023-02-04	2022-10-30	2022-07-31	2022-05-01	2022-01-29	2021-10-31	2021-08-01	2021-05-02	2021-01-30	2020-11-01	2020-08-02	2020-05-03	2020-01-31	2019-11-03	2019-08-04	2019-05-05	2018-08-05	2018-05-06	2018-02-03	2017-10-29	2016-10-30	2016-07-31	2016-05-01	2016-01-29	2015-11-01	2015-08-02	2015-05-03	2015-01-31	2014-11-02	2013-05-05	2013-02-02	2012-10-28	2012-07-29	2012-04-29	2012-02-03	2011-10-30	2011-07-31	2011-05-01

operating activities
net income	224,200,000	-44,800,000	131,900,000	158,000,000	151,400,000	206,700,000	161,600,000	94,200,000	136,000,000	601,900,000	-186,700,000	115,300,000	133,100,000	-360,800,000	279,700,000	181,800,000	99,700,000	2,031,400,000	69,500,000	-51,700,000	-1,097,200,000	-1,621,100,000	208,900,000	193,100,000	81,600,000	164,700,000	178,900,000	316,400,000	238,700,000	126,100,000	90,500,000	231,600,000	110,500,000	221,900,000	102,200,000	114,100,000	185,000,000	225,700,000	-20,013,000	-202,743,000	165,409,000	87,702,000	93,114,000	197,205,000	112,239,000	66,729,000	57,667,000
adjustments to reconcile to net cash from operating activities:
depreciation and amortization	68,700,000	67,700,000	69,700,000	69,800,000	72,100,000	59,200,000	75,200,000	75,500,000	72,300,000	73,300,000	73,100,000	75,400,000	76,800,000	68,300,000	77,300,000	78,300,000	77,600,000	73,100,000	80,200,000	78,900,000	81,100,000	89,300,000	81,600,000	78,400,000	76,500,000	83,000,000	83,200,000	95,800,000	81,200,000	84,400,000	82,600,000	70,600,000	134,800,000	63,000,000	63,000,000	61,000,000	76,000,000	60,300,000	95,843,000	211,050,000	34,752,000	34,333,000	33,459,000	41,588,000	32,321,000	31,966,000	34,481,000
equity in net income of unconsolidated affiliates	-12,200,000	-10,500,000	-10,600,000	-10,900,000	-13,200,000	-13,400,000	-13,700,000	-9,200,000	-11,900,000	-3,100,000	-10,500,000	-24,700,000	-7,400,000										-2,900,000	-900,000	-3,700,000	-3,300,000	-3,800,000	-15,500,000					14,900,000	-6,400,000	-2,500,000	-6,100,000
deferred taxes	-135,700,000	-342,300,000	-4,600,000	-1,800,000	-5,500,000	3,200,000	-6,700,000	-19,100,000	-3,000,000	67,900,000	-68,800,000	-12,600,000	-900,000	-77,200,000	31,100,000	24,600,000	31,300,000	95,000,000	-9,100,000	-22,900,000	-127,900,000	-147,300,000	23,200,000	-10,500,000	-10,100,000	-12,600,000	5,600,000	-45,900,000	-19,300,000	14,400,000	-4,300,000	500,000	16,900,000	-27,400,000	4,000,000	7,800,000	-6,200,000	7,100,000	-37,129,000	-88,677,000	13,445,000	9,196,000	3,858,000	33,330,000	7,747,000	7,390,000	1,520,000
stock-based compensation expense	13,900,000	12,100,000	12,200,000	16,400,000	10,500,000	14,500,000	12,100,000	14,300,000	13,100,000	16,600,000	12,500,000	12,700,000	10,100,000	10,800,000	11,300,000	13,800,000	10,700,000	10,200,000	14,800,000	11,800,000	10,000,000	7,300,000	14,900,000	14,400,000	13,900,000	15,200,000	11,600,000	23,200,000	11,900,000	9,400,000	9,200,000	10,300,000	6,800,000	11,000,000	11,900,000	8,500,000	4,700,000	12,900,000	18,897,000	31,582,000	7,481,000	8,375,000	10,516,000	2,481,000	10,468,000	10,927,000	9,723,000
impairment of goodwill and other intangible assets	0	479,500,000																	0	0	933,500,000
other gain			-9,500,000	0	-10,000,000
changes in operating assets and liabilities:
trade receivables	-32,000,000	21,800,000	-95,200,000	-71,900,000	-19,500,000	66,000,000	-185,000,000	22,800,000	13,400,000	416,400,000	-198,300,000	10,200,000	-109,400,000	87,500,000	-85,100,000	20,800,000	-211,700,000	-103,800,000	-227,000,000	6,200,000	186,500,000	334,600,000	-191,800,000	81,900,000	-86,300,000	65,200,000	-145,400,000	38,400,000	-181,800,000	-220,900,000	85,000,000	12,700,000	154,600,000	-238,300,000	134,800,000	-28,800,000	202,000,000	-167,300,000	-69,356,000	90,627,000	-168,372,000	107,706,000	-61,611,000	227,876,000	-211,584,000	93,537,000	-54,135,000
other receivables	-5,500,000	13,600,000	-4,700,000	4,300,000	-800,000	-13,700,000	2,800,000	-3,300,000	4,200,000	11,400,000	9,100,000	7,900,000	-21,200,000	3,900,000	-7,300,000	7,500,000	-5,400,000	700,000	7,700,000	-5,700,000	1,400,000	2,000,000	-200,000	-1,200,000	600,000
inventories	-174,000,000	-24,300,000	-32,900,000	-225,200,000	69,900,000	-364,900,000	229,900,000	-75,000,000	76,200,000	898,600,000	-175,100,000	-337,800,000	-78,100,000	-454,900,000	44,000,000	-19,500,000	-36,500,000	-207,600,000	148,400,000	-10,500,000	35,800,000	251,000,000	98,900,000	-166,400,000	99,800,000	-242,200,000	33,900,000	-112,500,000	20,800,000	126,300,000	-145,700,000	90,100,000	96,300,000	70,500,000	-248,000,000	83,400,000	-100,600,000	93,100,000	170,595,000	6,315,000	66,406,000	-193,173,000	76,145,000	75,840,000	38,495,000	-194,487,000	22,634,000
accounts payable, accrued expenses and deferred revenue	229,000,000	-217,100,000	-38,400,000	365,700,000	-328,200,000	453,500,000	-205,200,000	162,000,000	-315,000,000	-374,800,000	47,200,000	280,200,000	-271,400,000	-115,000,000	48,700,000	172,600,000	-168,900,000	75,400,000	106,700,000	341,400,000	-262,800,000	229,100,000	-86,900,000	285,300,000	-286,600,000	319,300,000	-313,800,000	188,600,000	-95,500,000	-52,900,000	158,100,000	-174,000,000	257,800,000	-45,900,000	149,800,000	-194,800,000	236,100,000	-81,200,000	-330,942,000	-2,397,000	-78,742,000	202,353,000	-162,460,000	91,049,000	7,801,000	117,378,000	-129,635,000
prepaid expenses	3,700,000	-42,200,000	12,200,000	30,600,000	-26,600,000	26,500,000	42,400,000	-1,600,000	-44,300,000	22,000,000	-6,100,000	-9,300,000	-36,700,000	-44,800,000	2,600,000	9,900,000	-9,600,000	-47,200,000	21,300,000	6,600,000	-1,400,000	22,800,000	22,100,000	-9,000,000	-28,000,000	5,600,000	-21,400,000	38,200,000	2,100,000	12,500,000	-3,400,000	2,600,000	19,500,000	16,100,000	13,500,000	-29,900,000	23,800,000	2,100,000	-20,656,000	22,409,000	38,601,000	-12,805,000	4,215,000	-54,881,000	4,953,000	1,394,000	4,259,000
other	33,000,000	15,100,000	-1,400,000	-42,600,000	33,200,000	-27,300,000	2,100,000	11,000,000	-16,400,000	30,700,000	-26,100,000	-20,600,000	1,700,000	-99,700,000	-26,100,000	28,600,000	-700,000	-168,600,000	-29,100,000	26,000,000	67,900,000	112,800,000	-54,700,000	35,000,000	-19,800,000	27,500,000	60,100,000	76,600,000	-16,400,000	-7,400,000	11,400,000	17,700,000	-59,600,000	900,000	32,300,000	45,200,000	59,800,000	6,500,000	67,741,000	133,286,000	2,293,000	-36,214,000	4,180,000	-104,306,000	13,295,000	11,872,000	25,230,000
net cash from operating activities			28,700,000											-544,000,000	251,000,000			644,200,000	179,000,000			265,900,000	113,900,000					609,400,000	40,200,000	167,700,000	299,500,000	109,200,000	566,700,000	65,100,000			575,700,000	153,700,000		126,481,000	78,080,000			396,197,000	37,595,000
capex			-40,000,000											-119,400,000	-60,500,000			-109,200,000	-51,100,000			6,500,000	-82,600,000					0	-79,200,000	-60,200,000	-56,900,000	-45,900,000	-77,600,000	-68,100,000			0	-70,800,000		-100,094,000	-55,363,000			-92,662,000	-43,993,000
free cash flows			-11,300,000											-663,400,000	190,500,000			535,000,000	127,900,000			272,400,000	31,300,000					609,400,000	-39,000,000	107,500,000	242,600,000	63,300,000	489,100,000	-3,000,000			575,700,000	82,900,000		26,387,000	22,717,000			303,535,000	-6,398,000
investing activities
purchases of property, plant and equipment	-31,200,000	-26,700,000	-40,000,000	-36,600,000	-38,800,000	4,600,000	-47,400,000	-58,000,000	-57,900,000	-49,900,000	-86,100,000	-56,300,000	-52,400,000	-119,400,000	-60,500,000	-61,100,000	-49,100,000	-109,200,000	-51,100,000	-51,200,000	-56,400,000	6,500,000	-82,600,000	-73,800,000	-76,700,000	-88,200,000	-76,700,000
proceeds from sale of warner’s, olga and true&co. women’s intimates businesses	0	2,500,000	2,500,000
purchases of investments held in rabbi trust	-4,300,000	-4,300,000	-1,100,000	-500,000	-2,500,000	-2,200,000	-900,000	-500,000	-1,900,000	2,100,000	-1,100,000	-600,000	-5,100,000
proceeds from investments held in rabbi trust	4,500,000	500,000	500,000	300,000	100,000	1,200,000	400,000	700,000	200,000	2,300,000	0	200,000	400,000
proceeds from cross-currency swap contracts			0
net cash used by investing activities	-31,000,000	-28,000,000	-28,600,000	-30,800,000	-41,200,000	27,600,000	-47,900,000	-57,800,000	-59,600,000			-37,600,000	-57,100,000									309,500,000	-85,200,000	-206,700,000	-76,700,000	-88,200,000	-92,600,000	-83,400,000	-106,600,000	-95,200,000	-52,300,000	-218,200,000	-270,500,000	-83,200,000	-64,600,000	-62,600,000	-81,300,000	-89,600,000	-1,875,259,000	-1,869,583,000	-80,312,000	-54,825,000	-52,609,000	-81,145,000	-112,734,000	-56,267,000	-57,787,000
financing activities
net proceeds from short-term borrowings		115,000,000									87,700,000	-3,400,000	6,400,000			5,400,000	13,300,000			-256,700,000	272,000,000		204,500,000	-167,000,000	286,900,000		235,000,000					15,100,000				2,100,000									-186,000	729,000	7,409,000
repayment of 2022 facilities	-3,200,000	-3,000,000	-3,100,000	-2,900,000	-3,000,000	-2,900,000	-2,900,000	-3,000,000	-3,000,000
net proceeds from settlement of awards under stock plans	1,300,000	100,000	0	300,000	7,000,000			0	100,000			0	100,000		15,700,000	3,900,000	1,400,000					2,000,000	0	0	1,900,000	7,100,000	13,300,000	9,000,000	4,200,000	2,000,000	9,500,000	800,000	7,400,000	400,000	1,900,000	3,400,000	-2,100,000	2,800,000	10,062,000				3,738,000	1,007,000	703,000	3,154,000	8,407,000
proceeds from senior notes, net of related fees
repayment/redemption of senior notes
cash dividends	-2,000,000	-1,900,000	-2,100,000	-2,100,000	-2,200,000	-1,500,000	-2,300,000	-2,400,000	-2,400,000	-1,700,000	-2,500,000	-2,600,000	-2,600,000					0	0	0	-2,700,000	8,600,000	-2,800,000	-2,800,000	-5,700,000	-2,900,000	-5,900,000	200,000	-2,900,000	-3,000,000	-3,000,000	-6,200,000	300,000	-3,100,000	-3,200,000	-6,200,000	0	-3,100,000	-6,130,000	-4,056,000	-2,747,000	-7,000	-5,483,000	-2,832,000	-2,719,000	-20,000	-5,414,000
acquisition of treasury shares	-4,800,000	-572,200,000	-34,800,000	-31,400,000	-214,000,000	-238,100,000	-72,500,000	-209,600,000	-4,600,000	-227,800,000	-104,800,000	-129,700,000	-108,000,000	-257,800,000	-148,600,000	-3,000,000	-9,200,000	-245,200,000	-200,000	-1,100,000	-114,800,000	122,900,000	-95,500,000	-67,200,000	-77,500,000	-87,000,000	-75,100,000	-125,000,000	-70,000,000	-95,700,000	-80,900,000	-53,000,000	-234,800,000	-60,500,000	-17,700,000	-9,100,000	-127,900,000	-200,000	-20,130,000	-47,480,000	-322,000	-7,451,000	-6,182,000	-8,727,000	-70,000	-3,132,000	-2,055,000
payments of finance lease liabilities	-900,000	-900,000	-900,000	-1,100,000	-1,100,000	-500,000	-900,000	-1,300,000	-1,200,000	-1,600,000	-800,000	-1,200,000	-1,000,000	-800,000	-1,100,000	-1,400,000	-1,400,000	-1,200,000	-1,300,000	-1,400,000	-1,300,000	-1,400,000	-1,200,000	-1,400,000	-1,500,000
net cash used by financing activities	-130,600,000	-462,900,000	-49,200,000	-28,900,000	-221,900,000	-219,600,000	-74,600,000	-217,300,000	-38,900,000	-436,800,000	-29,600,000	-143,400,000	-112,000,000															-414,200,000				-97,100,000	-27,100,000	-78,700,000							10,008,000
effect of exchange rate changes on cash and cash equivalents	6,300,000	5,300,000	-1,300,000	1,100,000	-1,600,000	-3,700,000	-8,200,000	2,500,000	-3,000,000	37,300,000	-12,900,000	-8,700,000	-21,300,000	-11,500,000	-5,900,000	-6,800,000	-400,000	-55,700,000	-7,200,000	35,300,000	-9,000,000	43,000,000	-1,800,000	-3,100,000	-6,100,000	-13,600,000	-7,100,000	-35,900,000	-200,000	-6,300,000	-2,800,000	14,800,000	14,000,000	0	-12,700,000	1,700,000	-15,600,000	-8,600,000	-7,082,000	-7,523,000	6,868,000	-9,751,000	1,933,000	4,711,000	-4,177,000	-3,113,000	15,172,000
decrease in cash and cash equivalents	57,800,000	-557,000,000	-50,400,000	233,800,000	-331,400,000		-15,200,000	-1,000,000	-176,900,000		-242,300,000	-49,400,000	-493,800,000													-3,400,000	-59,400,000					-191,300,000		-96,800,000	47,400,000	-60,000,000		-96,000,000
cash and cash equivalents at beginning of period	0	748,000,000	0	0	707,600,000		0	0	550,700,000		0	0	1,242,500,000		0	0	1,651,400,000		0	0	503,400,000		0	0	452,000,000	0	493,900,000		0	0	0	556,400,000		0	0	479,300,000		0	892,209,000		0	0	233,197,000		0	0	498,718,000
cash and cash equivalents at end of period	57,800,000	191,000,000	-50,400,000	233,800,000	376,200,000		-15,200,000	-1,000,000	373,800,000		-242,300,000	-49,400,000	748,700,000		146,100,000	239,400,000	913,200,000		65,700,000	593,600,000	800,700,000		121,700,000	-60,800,000	494,300,000	-3,400,000	434,500,000		52,900,000	-79,300,000	376,600,000	365,100,000		-96,800,000	47,400,000	419,300,000		-96,000,000	746,281,000		14,644,000	23,374,000	238,612,000		-127,710,000	-7,267,000	294,958,000
adjustments to reconcile to net cash used by operating activities:
net cash used by operating activities		-71,400,000			-66,700,000				-75,400,000				-303,400,000				-189,100,000				-142,800,000				-73,200,000		-125,700,000												-116,952,000				-508,000				-12,023,000
proceeds from 4 1/8% senior notes, net of related fees			0	0	553,100,000
redemption of 3 5/8% senior notes			0	0	-561,700,000
proceeds from sale of warehouse and distribution center
net payments on short-term borrowings																																							-24,723,000
net proceeds from (payments on) short-term borrowings														8,500,000																							-14,200,000	-128,700,000
impairment of goodwill
impairment of other long-lived assets										-37,900,000	0			16,600,000	0	7,000,000	28,100,000	23,800,000	0	7,200,000	16,000,000
actuarial gain on retirement and benefit plans
proceeds from sale of karl lagerfeld investment										-17,700,000	0
net (payments on) proceeds from short-term borrowings							4,100,000	-1,000,000	-27,800,000																															-31,402,000	-277,000	398,000	-647,000
proceeds from 2022 facilities, net of related fees
repayment of 7 3/4% senior notes
repayment of 2019 facilities											-9,100,000	-6,500,000	-6,900,000	356,400,000	-136,800,000	-203,700,000	-503,700,000	-1,040,700,000	-3,700,000	-3,500,000	-3,400,000	-4,200,000
increase in cash and cash equivalents														-339,100,000	146,100,000	239,400,000	-738,200,000	-1,365,500,000	65,700,000	593,600,000	297,300,000	1,044,800,000			42,300,000			75,900,000	52,900,000	-79,300,000									-145,928,000	-342,483,000	14,644,000	23,374,000	5,415,000	997,749,000			-203,760,000
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
adjustments to reconcile to net cash provided (used) by operating activities:
net cash provided (used) by operating activities							115,500,000																													60,400,000
proceeds from sale of van heusen, izod, arrow and geoffrey beene trademarks and other assets
payment of mandatorily redeemable non-controlling interest liability attributable to initial fair value															0			-2,500,000	0
adjustments to reconcile to net cash (used) provided by operating activities:
net cash (used) provided by operating activities											-112,600,000
proceeds from sale of certain heritage brands trademarks and other assets
net cash (used) provided by investing activities																-61,100,000	-49,100,000
equity in net (income) loss of unconsolidated affiliates														-36,300,000	-6,300,000	-4,100,000	-3,700,000
other (gain) loss
investments in unconsolidated affiliates																						900,000									0	-1,500,000		-4,000,000	-200,000	-22,400,000	-400,000	0		-1,568,000
proceeds from sale of the speedo north america business																			0	0	169,100,000
proceeds from 4 5/8% senior notes, net of related fees																			-1,000,000
proceeds from 3 5/8% senior notes, net of related fees																			0											0
net cash (used) provided by financing activities														546,800,000	-261,400,000	-214,000,000	-499,600,000																			-59,500,000	-173,600,000	-151,500,000							-48,394,000	-95,655,000	-149,122,000
net cash from investing activities
other noncash loss																					3,100,000
actuarial (gain) loss on retirement and benefit plans
debt modification and extinguishment costs																							0	0	5,200,000					0								0	40,395,000						0
employer pension contributions																																	-98,500,000				1,200,000		-30,000,000
acquisitions, net of cash acquired																							-100,000			0	-15,900,000
proceeds from sale of building																							0							0
proceeds from 2019 facilities, net of related fees																							0	-3,700,000	1,643,500,000
repayment of 2016 facilities																							0	0	-1,649,300,000
equity in net income (income) of unconsolidated affiliates																			-4,400,000	3,500,000	11,200,000										300,000	200,000
other noncash gain																			0				0
employer pension contribution
net cash provided (used) by investing activities																			-52,700,000	-51,200,000	112,700,000
net cash from financing activities																					336,400,000				198,300,000														1,853,365,000
net cash provided (used) by financing activities																						426,400,000					166,000,000																56,599,000
proceeds from 3 5/8 senior notes, net of related fees																					186,600,000
contingent purchase price payments to mr. calvin klein																										-1,300,000	-14,600,000
repayment of 2016/2014 facilities																												-100,000,000	0	-50,100,000
impairment of long-lived assets																							1,500,000	4,100,000	83,700,000			15,700,000					7,300,000	1,200,000			6,600,000	2,500,000		8,498,000	0			5,262,000	1,151,000
actuarial loss on retirement and benefit plans
settlement loss on retirement plans																													0
payment received on advance to unconsolidated affiliate																													0
proceeds from 3 1/8% senior notes, net of related fees
redemption of 4 1/2% senior notes, including premium
tommy hilfiger india contingent purchase price payments
contributions from non-controlling interest																													0
payments of capital lease obligations																										-1,300,000	-1,300,000	-1,600,000	-1,300,000	-1,700,000	-1,600,000	-2,000,000	-1,400,000	-1,800,000	-1,900,000	-1,900,000	-1,200,000	-2,100,000	-2,348,000	-1,031,000	-2,901,000	-3,217,000	-2,447,000	-3,176,000
gain to write-up equity investment in joint venture to fair value																														0	0	-153,100,000
net income on deconsolidation of subsidiary
investments in and advance to unconsolidated affiliates
loan to a supplier
proceeds from 2016 facilities, net of related fees																														0
repayment of term loan b in connection with amendment to 2014 facilities																														0
loss to write-down assets held for sale
business acquisitions, net of cash acquired																													-12,000,000	0	300,000	-158,000,000						-7,300,000	-1,815,329,000	-1,808,258,000				-12,856,000
purchase of property, plant and equipment																													-79,200,000	-60,200,000	-56,900,000	-45,900,000	-77,600,000	-68,100,000	-52,400,000	-48,500,000		-70,800,000	-45,730,000	-100,094,000	-55,363,000	-42,611,000	-39,074,000	-92,662,000	-43,993,000	-39,432,000	-34,467,000
contingent purchase price payments																													-12,900,000	-11,800,000	-12,400,000	-12,800,000	-18,700,000	-11,100,000	-12,000,000	-11,900,000	-15,800,000	-11,500,000	-14,200,000	-17,508,000						-12,335,000	-12,970,000
change in restricted cash																																				20,200,000	10,500,000	0
investments in and note receivable to unconsolidated affiliates
excess tax benefits from awards under stock plans																														400,000	400,000	100,000	-4,100,000	1,600,000	1,400,000	2,000,000	-3,800,000	4,700,000	14,788,000	29,312,000	1,245,000	4,170,000	2,912,000	10,329,000	322,000	1,798,000	2,440,000
repayment of 2014 facilities																																-51,900,000		-34,800,000	-115,900,000	-49,800,000
net gain on deconsolidation of subsidiaries and joint venture																																						0
redemption of 7 3/8% senior notes, including make whole premium																																						0
proceeds from 2016/2014 facilities, net of related fees
business acquisitions
decrease in restricted cash																																		0
proceeds from 2014 facilities, net of related fees
write-down of assets related to sale of bass
gain on amendment of contract
cash received for sale of bass
cash received for sale of chaps sportswear assets
repayment of 2011 facilities
repayment of warnaco’s previously outstanding debt																																							-197,000,000
proceeds from 2014/2013 facilities, net of related fees																																						0
repayment of 2014/2013 facilities																																					-105,300,000	-24,900,000
payment of fees associated with issuance of senior notes																																							-16,257,000
equity in income of unconsolidated affiliates																																						-5,300,000	-2,327,000	-3,013,000	-3,193,000	74,000	-1,924,000
write-down of assets held for sale
payment of fees associated with issuance of 4 1/2% senior notes
net proceeds from revolving credit facilities																																							1,673,000	-129,050,000	90,000,000
repayment of old credit facilities
repayment of new credit facilities
net proceeds from new credit facilities
repayment of credit facilities																																							-900,000,000		-77,734,000	-59,388,000	-30,292,000	-13,355,000	-38,784,000	-98,184,000	-149,275,000
net proceeds from credit facilities																																							2,993,430,000
(gain) loss on (amendment) settlement of contracts
proceeds from new credit facilities, net of related fees
payment of 2011 debt modification and extinguishment costs
proceeds from issuance of senior notes
debt modification costs																																															16,233,000
expense recorded for settlement of unfavorable contract
payment of debt modification costs																																													0	0	-10,634,000
proceeds from settlement of awards under stock plans																																									2,744,000
calvin klein contingent purchase price payments																																										-12,214,000	-13,535,000
proceeds from revolving credit facilities																																											165,000,000		0	0	60,000,000
payments on revolving credit facilities																																											-70,000,000		0	0	-60,000,000
disposal of goodwill
losses on settlement of derivative instruments related to the acquisition of tommy hilfiger
payment of consent fees
net proceeds from common stock offering
net proceeds from preferred stock issuance
net proceeds from issuance of long-term debt
extinguishment of debt
investments in equity-method investees
investment in joint venture																																														-4,500,000	-10,350,000
unrealized losses on derivative instruments related to the acquisition of tommy hilfiger
loss on settlement of derivative instruments related to the acquisition of tommy hilfiger
debt extinguishment costs
gain on sale of investments
proceeds in connection with acquisition of cmi
sale of investments
net proceeds from issuance of debt
net proceeds from short term borrowings

We provide you with 20 years of cash flow statements for PVH Corp stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PVH Corp stock. Explore the full financial landscape of PVH Corp stock with our expertly curated income statements.

The information provided in this report about PVH Corp stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.